SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: J Stone who wrote (27763)2/2/1999 4:20:00 PM
From: dwc  Read Replies (1) | Respond to of 32384
 
Another day without the sunshine of FDA approval...still got three days this week

The heck with takeover rumors, let's see the approval rumors first



To: J Stone who wrote (27763)2/2/1999 6:33:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
ZEN has Tamoxifen, and ZEN is supposed to merge with Astra, but there are many hostile (by GLX and Norvartis, among many) takeover rumors. Of course there is also a BMY takeover rumor, so in the end BMY (as part of a larger entity) may actually end up owning Tamoxifen.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News